Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
9.87
+0.52 (5.56%)
At close: Jan 21, 2026, 4:00 PM EST
9.67
-0.20 (-2.03%)
After-hours: Jan 21, 2026, 7:08 PM EST

Neogen Revenue

Neogen had revenue of $224.69M in the quarter ending November 30, 2025, a decrease of -2.84%. This brings the company's revenue in the last twelve months to $880.32M, down -3.67% year-over-year. In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%.

Revenue (ttm)
$880.32M
Revenue Growth
-3.67%
P/S Ratio
2.43
Revenue / Employee
$296,005
Employees
2,974
Market Cap
2.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 31, 2025894.66M-29.56M-3.20%
May 31, 2024924.22M101.78M12.37%
May 31, 2023822.45M295.29M56.01%
May 31, 2022527.16M58.70M12.53%
May 31, 2021468.46M50.29M12.03%
May 31, 2020418.17M3.98M0.96%
May 31, 2019414.19M16.26M4.09%
May 31, 2018397.93M39.65M11.07%
May 31, 2017358.28M37.00M11.52%
May 31, 2016321.28M38.20M13.50%
May 31, 2015283.07M35.67M14.42%
May 31, 2014247.41M39.88M19.22%
May 31, 2013207.53M23.48M12.76%
May 31, 2012184.05M11.36M6.58%
May 31, 2011172.68M32.17M22.90%
May 31, 2010140.51M21.79M18.35%
May 31, 2009118.72M16.30M15.92%
May 31, 2008102.42M16.28M18.90%
May 31, 200786.14M13.71M18.92%
May 31, 200672.43M9.68M15.42%
May 31, 200562.76M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
NeoGenomics709.16M
OPKO Health642.07M
Veracyte495.14M
GeneDx Holdings402.19M
Twist Bioscience376.57M
CareDx358.00M
Castle Biosciences343.53M
Fulgent Genetics315.55M
Revenue Rankings